TNF and cancer: Smac-mimetics LCL161 compound has been developed as an antagonist of the cellular inhibitor of apoptosis cIAP-1 and -2 and has been unsuccessfully evaluated in clinical trials for its ability of induce TNF-mediated apoptosis of cancer cells [12, 21].